Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

End-of-Life Racial Disparities in Ovarian Cancer

J Clin Oncol; ePub 2017 Apr 7; Taylor, et al

Ethnic minorities with ovarian cancer are more apt to receive intensive and invasive end-of-life care, according to a study involving more than 3,600 individuals.

Investigators looked at Medicare data from participants with ovarian cancer who died between 2000 and 2012. Among the results:

  • 7 in every 10 patients enrolled in hospice; nearly 90% of them died while enrolled.
  • Median hospice enrollment duration was 20 days.
  • In the month before death, 10% had >1 ER visit, 14% had >1 hospital admission, 16% had an ICU admission, 23% invasive care, and 11% life-extending care.
  • In the 2 weeks prior to death, 10% received chemotherapy.
  • Hispanics and blacks were less likely to enroll and die in hospice.
  • Hispanics were 37% more likely to be admitted to an ICU.
  • Blacks were more than twice as likely to both have >1 ER visit and receive a life-extending procedure.

Citation:

Taylor J, Rajan S, Zhang N, et al. End-of-life racial and ethnic disparities among patients with ovarian cancer. [Published online ahead of print April 7, 2017]. J Clin Oncol. doi:10.1200/JCO.2016.70.2894.